Objective-Low-density lipoprotein (LDL) size is associated with vascular disease and with familial combined hyperlipidemia (FCHL). Methods and Results-We used logarithm of odds (lod) score and Bayesian Markov chain Monte Carlo (MCMC) linkage analysis methods to perform a 10-cM genome scan of LDL size, measured as peak particle diameter (PPD) and adjusted for age, sex, body mass index, and triglycerides in 4 large families with FCHL (nϭ185 
C ardiovascular disease (CVD) remains the major cause of death in Western societies. Low-density lipoprotein (LDL) size, quantitatively measured as the peak particle diameter (PPD), has been shown to predict CVD. [1] [2] [3] A related trait, small, dense LDL is associated with myocardial infarction, 4 as well as with elevated apolipoprotein B (apoB), triglycerides (TGs), and decreased high-density lipoprotein cholesterol (HDL-C) levels. 4, 5 LDL size is highly correlated with HDL-C and TG levels, and examination of whether its predictive power in CVD is independent of these correlations has given contradictory results. [1] [2] [3] It has been hypothesized that small, dense LDL causes vascular disease directly through increased ability to permeate the vascular epithelium, or through increased susceptibility to oxidation, 6, 7 in addition to effects on other atherogenic traits.
The previous studies demonstrating that variation in LDL size is heritable were reviewed recently by Bosse et al. 8 Genetic heterogeneity is suggested by the linkage and association studies. Linkage of LDL size to cholesteryl ester transfer protein (CETP) and APOA1/C3/A5 has been described in families with familial combined hyperlipidemia (FCHL). 9 Only the CETP locus is well established to cause common variation in LDL size. 8 -11 Allayee et al also found weak evidence of linkage of LDL size to the manganese superoxide dismutase (MnSOD; chromosome 6q25), a region suggested in a study of familial hypertriglyceridemia. 12 Several strategies can be used to improve the power to detect evidence for linkage to a genetically complex trait such as LDL size. 13 First, large pedigrees are advantageous because they tend to have more power for linkage detection than do small pedigrees for an equivalent total number of individuals, 13, 14 and they also can be analyzed individually, which can reduce the problem of genetic heterogeneity. Second, ascertainment of pedigrees through an extreme phenotype that is related to the complex trait of interest can reduce the genetic heterogeneity and increase the potential for segregation at trait loci. Successful examples of these strategies include the mapping of BRCA1 and Alzheimer disease loci. 15, 16 Third, it can be helpful to take covariates into account, including correlated traits that also have a genetic basis, 13, 17 as underscored by the finding of significant evidence of lipoprotein lipase linkage to LDL size only when adjusted for TG. 18 The only previous genomic scan of LDL PPD that obtained significant results and used a TG covariate was of French-Canadians 19 that identified a 17q21 locus. Finally, it is useful to use methods of analysis that effectively efficiently accommodate the possibility of multilocus inheritance, such as Markov chain Monte Carlo (MCMC). 20 Families with FCHL, the most common genetic cause of hyperlipidemia, 21, 22 may represent a relatively homogeneous sample with respect to LDL density. The major lipid abnormalities seen in FCHL are an increase in TG or cholesterol caused by an increase in small very low-density lipoprotein, an increase in intermediate density lipoprotein, and an increase in small dense LDL. 9, 23, 24 Indeed, the small LDL and high apoB seen in FCHL are found whether the patient is hypercholesterolemic or hypertriglyceridemic. 25 Additionally, small LDL appeared to segregate and predict FCHL independently of a putative apoB level locus. 24 The relationship between LDL size and FCHL and the understanding of the need for proper covariate adjustments motivated the genomic scan for LDL size loci in large families presented here. The use of FCHL families may reduce genetic heterogeneity, as may the use of fewer, large families, improving power to detect linkage. Further, our segregation analyses determined that adjustment of TG was an important factor in ability to map LDL PPD loci. Only 1 genome scan of LDL PPD adjusted for TG with significant results has been reported, 19 and there has been no such genomic scan of LDL PPD in families with FCHL. The use of novel Bayesian MCMC analytic methods allows for: (1) consideration of multilocus trait models that are not prespecified, (2) multipoint linkage analyses using all chromosome markers simultaneously, and (3) comparison of these results to those of logarithm of odds (lod) score methods. Identification of LDL size loci will aid in diagnosis, treatment, and perhaps prevention of vascular disease, as well as help unravel the complex genetics of FCHL.
Methods

Families
Analyses were performed on members of 4 large white pedigrees with well-characterized FCHL. These pedigrees each include 3 generations of sampled adults and multiple large sibships and were described in detail previously. 24, 26 Pedigree 1 was identified through a survivor of a premature myocardial infarction with hyperlipidemia. The probands in pedigrees 2 to 4 were markedly hypertriglyceridemic and originally were thought to represent bilineal FCHL families. 27 These FCHL families were collected because of their large size. Pedigrees 1 to 4 have also been referred to previously as pedigrees 41, 428, 2100, and 2103, respectively. 14,26 Seven subjects were excluded from phenotype analyses: 3 had type II diabetes, and 4 were taking lipid-lowering medications. There were 185 remaining subjects with phenotype and genotype data; 45, 38, 64, and 38 subjects each in families 1 to 4, respectively. Body mass index (BMI) was computed using self-reported height and weight. This study was approved by the University of Washington Institutional Review Board.
Laboratory Methods
LDL PPD (size in nanometers) was determined by gradient gel electrophoresis of whole plasma. 28 -31 Standard enzymatic methods were used to determine levels of TG (UV method) and HDL-C on an Abbott Spectrum analyzer. 32, 33 
Genotyping and Error Resolution
Genotyping for the 10-cM genome scan was provided by the National Heart, Lung, and Blood Institute (NHLBI) Mammalian Genotyping Service (James Weber, Marshfield, Wis; NHLBI NO1-HV-48141). We used the Weber 9 panel of 387 markers, with an average heterozygosity across markers in our data set of 0.76 (SDϭ0.06). The average percentage of markers for which genotypes were obtained in an individual was 98.4%. The genotyping error, determined by blind duplicate samples, was 0.7%. Family structure errors, sample switches, and genotyping errors were identified and resolved through a combination of methods, including (1) evaluation of allele sharing in pairs of individuals under the assumption of a 0% genotyping error rate, as computed by RELPAIR; 34 (2) new methods to evaluate more complicated relationships among trios of individuals, with a model that allows for genotyping error, implemented in ECLIPSE; 35 and (3) computation of single-locus likelihoods on complete pedigrees for specific marker data. When pedigree structure problems could not be resolved, relevant individuals were removed from further analysis. Genotypes of individual markers with evidence of genotyping error were removed from any individuals for whom the presence of a genotype would be informative in a linkage analysis.
Covariate Adjustments
The primary trait was PPD adjusted for variability attributable to age, sex, BMI, and TG. Adjustment for TG was undertaken to map quantitative trait loci (QTLs) for LDL size rather than TG levels because these 2 variables are highly correlated, and our previous work demonstrated that adjustment for TG was crucial to identifying the strong linkage of LDL size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. 18 Segregation analyses discussed below further supported the increased power of mapping LDL size adjusted for PPD. Natural log TG (lnTG) was used because of the marked skewing of the TG distribution; [lnTG] 2 significantly predicted PPD (PϽ0.05) and was used for PPD adjustment. The linear term lnTG did not predict further variation in PPD (PϾ0.05).
For lod score analyses, linear regression across all 4 families was used to adjust for age, sex, BMI, and [lnTG] 2 . Each family had regression residuals for covariates adjusted to a mean of zero, eliminating differences in mean family LDL size. The resulting adjusted trait for the individual and combined family lod score analyses is PPD asbt . Secondary lod score analyses were done without [lnTG] 2 adjustment (PPD asb ) to determine whether TG adjustment influenced the linkage signals.
For MCMC analyses, the same covariates were considered as part of the joint linkage and segregation analyses. The MCMC trait was termed PPD asbt2 as a reminder that the lod score and MCMC analyses include the same covariates, but they are used differently. The MCMC approach accounts for the relationship among individuals, whereas the regression approach assumes that individuals are unrelated. Nevertheless, the coefficient differences between the resulting estimates were small (data not shown). For MCMC analyses, but not for the lod score analyses, covariate adjustments differ among individual family analyses.
Segregation Analyses
Complex segregation analysis (CSA) was performed on PPD asbt to estimate parameter values for Mendelian transmission models used in the lod score linkage analyses. Separate models were generated for individual families and for all families combined. PAP version 5 was used to compute likelihoods for the models considered. 36, 37 PAP approximations are fairly good even for very large pedigrees. 38, 39 No ascertainment correction was undertaken as a result of the lack of information on the relationship of the FCHL-based ascertainment to the PPD trait. Likelihood surfaces were interrogated repeatedly and systematically to avoid acceptance of a local maximum.
Lod Score Linkage Analyses
The lod score approach to linkage analysis 40 as implemented by FASTLINK 41, 42 was used. This model-based approach is expected to have highest power to detect linkage if the Mendelian models considered are approximately correct. The basic genome scan used 2-point (1-marker) and 3-point (2-marker) linkage analysis with PPD asbt . Two-point methods for linkage detection are less sensitive than multipoint methods to model misspecifications, 43, 44 and are not affected by map misspecification, whereas multipoint methods provide more linkage information. Multipoint methods provide a valid test of linkage even when model misspecification may lead to biased estimates of location. Allele frequencies were estimated from our larger set of 15 FCHL families, the remaining 11 of which did not have PPD measure available, to avoid false-positive results attributable to low allele frequencies. 45 Regions with 2-point maximum lod scores (z max ) Ն1 for all families, z max Ն2 for single families, 3-point z max Ͼ2, or intensity ratios (IRs) Ն20 from the MCMC analyses were followed by multipoint lod score analyses with sets of 3 adjacent markers and adjusted PPD. Multipoint analyses used sex-specific map distances obtained from the Marshfield Medical Research Foundation web site converted to Haldane distances. In addition to gaining comparability with the MCMC analyses (below) that currently only use the Haldane map function, this map function is somewhat more robust to trait model misspecification for the lod score analyses because of the longer resulting genetic map. Sexspecific maps were used because sex-averaged map results can inflate the lod score when the male and female maps differ in length. 46 Chromosomal locations are referred to here using the sex-averaged Haldane map. Sensitivity of analyses to marker allele frequencies were performed for regions with a z max Ն2 by increasing all rare marker frequencies to 0.025. This did not appreciably change the results. Multipoint lod score analyses were limited to 3 markers and a small number of regions because of the excessive computing time needed to carry out these analyses. The large size of the pedigrees allowed us to evaluate the possibility of genetic heterogeneity by examining the 4 families together and independently.
MCMC Linkage Methods
A Bayesian MCMC approach, as implemented in the computer program Loki, 20, 47 was also used for linkage analysis. Unlike the lod score method, these MCMC analyses allow for multiple QTLs, with the number of QTLs treated as a random variable and estimated in a joint linkage and segregation analyses. Thus, the genetic model is oligogenic and not prespecified. Loki version 2.4.5 was used for analysis. Details for carrying out the steps of the analyses are described previously. 47, 48 The information on unobserved multilocus marker states obtained with this program was shown recently to agree well with other estimates and to be superior to estimates obtained with multipoint approximation methods. 49, 50 In the analyses presented here, the MCMC sampler was run for 100 000 iterations, with every second iteration retained for estimating posterior distributions.
These MCMC methods require specification of previous distributions for analysis. For the number of QTLs in the model, a Poisson distribution with a mean of 2 was assumed, based on the mean number of loci contributing Ն10% of the total variance in a preliminary MCMC segregation analyses. The value for the variance in the genotype effect ( ␤ ) was similarly obtained by varying ␤ in short segregation analysis-only runs and using the value that maximized the genetic variance. Allele frequencies were assumed uniform on 0 to 1. Marker allele frequencies were estimated within each MCMC run. Loki uses the Haldane map function for multipoint analysis, and for these analyses, sex-average maps were used.
As for the lod score analyses, the MCMC analyses were performed on all families combined and on each family separately. Each MCMC genome scan consisted first of an analysis of each chromosome using all markers on the chromosome in a single multipoint analysis. Second, all regions showing positive evidence of linkage were reanalyzed with single-marker analyses to ensure that there were no false-positive results from map distance misspecification or use of sex-average maps. 46 All model parameters and covariate adjustments were simultaneously estimated within each joint MCMC linkage and segregation iteration. Thus, each MCMC iteration potentially considers a different model. Although MCMC methods are more robust than lod score methods to genetic heterogeneity, 51, 52 it was not known a priori whether a combined analysis of all 4 families would detect a locus that segregated in only 1 family, nor was it clear that enough data existed within 1 family to estimate all parameters simultaneously in the MCMC methods because the oligogenic model requires a large number of parameters.
There is no standard score that can be related easily to the lod score or to a P value to evaluate the strength of evidence for linkage. A commonly used measure of support in Bayesian analyses is the Bayes factor (BF), 53 which is the ratio of the odds under 2 hypotheses compared. In an MCMC linkage analysis, the hypotheses that can be compared are that of linkage versus that of uniform QTL locations on the genome. A statistic that approximates the BF is the ratio of posterior to previous probabilities of linkage, and 2 estimates of this statistic are the L-score and the IR. 47, 48 The L-score represents the expectation of the probability ratio over the MCMC run, and the IR represents the ratio of the expectations of the same probabilities. L-score and IR are conservative estimates of the BF. We use the IR here because it is somewhat less conservative, where evidence of linkage is reasonably strong. 48 
Results
Models From CSA
When a single Mendelian model for PPD asbt transmission was generated for the combined families, it was most similar to the family 1-specific model ( Table 1 ). The proportion of the total trait variance attributable to the codominant major locus (Vg/Vt) estimated by the combined family model was 0.60, and the polygenic variance was near zero. The correlation between LDL PPD and BMI was Ϫ0.36 and between LDL PPD and TG was Ϫ0.64. When PPD asb was considered, the model was substantially different (Table 1) , with a rarer allele and larger genotype mean deviations. For PPD asb , the Vg/Vt of 0.36 was substantially lower than the 0.60 found for PPD asbt . The larger contribution of the major locus component to the variance supports using PPD asbt as the trait of interest.
Linkage Analyses
Four regions gave results that strongly supported linkage. These results are summarized here. All regions with significant or suggestive linkage analysis results are summarized in Table 2 . The single and 2-marker lod scores for all families and each family individually for the entire genome scan, as well as the parametric multipoint plots, are available online at http://www.atvb.ahajournals.org.
The strongest evidence for linkage found by analysis of individual families was on chromosome 9 ( Figure 1 ; Table 2 ). These analyses were based on the family-specific CSA models for PPD asbt . In family 1, a multipoint z max ϭ3.70 was found at D9S921 using the 3 telomeric 9p markers in family 1. The 2-point z max ϭ2.89 at marker D9S921 (24 cM; 9p23) and 3-point z max ϭ3.66 (D9S2169/D9S921). The regional z max for the remaining individual families were low or zero. Using the MCMC method, chromosome 9 yielded an IR of 21 at 24 cM (9p23-ter) in family 1. To determine whether the differing covariate adjustments resulted in differences between the MCMC and lod score method analyses in the single family analyses, PPD asbt was used as the trait in the MCMC analyses, rather than estimating the covariate adjustments within the joint linkage and segregation analysis. In family 1, the IR for PPD asbt2 of 21 increased to 52 at 17 cM when the preadjusted PPD asbt values were used as input.
Considering the 4 families combined, there was significant evidence for linkage to regions of chromosomes 11, 14, and 16 ( Figure 1 ; Table 2 ). These lod score analyses considered the model from the joint segregation analysis of all 4 families. On chromosome 11, z max ϭ3.72 with 3-point analysis using markers D11S2371 and D11S2002 (95 cM). The 2-point z max ϭ1.52 with D11S2371 (85 cM; 11q13). The MCMCcombined family scan yielded an IR of 120 at 93 cM (chromosome 11q22). Considering the families individually, the 3-point z max was 0.60, 1.30, 1.36, and 1.01 under the all-family model and 0.70, 0.44, 1.37, and 0.11 under the family-specific models for families 1 to 4, respectively. The maximum single family IR was 13.4 in family 2. IRs were Ͻ3 in the other families.
MCMC analyses yielded a signal of IRϭ71 at 85 cM on chromosome 14q. This region did not provide a lod score Ͼ3. The 2-marker z max ϭ1.77 with markers D14S592 (74 cM) and D14S588 (84 cM); the 2-point z max ϭ1.51 with D14S588. This signal was largely attributable to family 4, which had a 3-marker z max ϭ2.37. The remaining families had z max ranging from 0.3 to 0.4. The single-family IR was 24.3 in family 4 and 6.7 in family 2.
For chromosome 16, the 3-marker (D16S3253-GATA67G11-D16S2624) multipoint z max for the combined families was 3.00 near D16S516 (110 cM; 16q23), with a second peak of z max ϭ2.22 near D16S753. The 2-point z max ϭ1.66 at GATA67G11 (89 cM; 16q21). The 2-marker z max ϭ2.83 (D16S3253-GATA67G11) for the 4 families combined with 2.29, 0.37, 0.91, and 1.18 for families 1 to 4, respectively, using D16S3253-GATA67G11 or adjacent markers GATA67G11-D16S2624 and the combined family model. Family 1 has a very wide region with a 2-marker z max Ͼ1.5, but under the family-specific model, the peak shifted from D16S3253-GATA67G11 to D16S753-D16S3396. This shift, some 20 cM toward the p-terminus, places the peak closer to the CETP locus ( Figure 2) . The MCMC IRϭ43, with a wide peak centered at 105 cM on chromosome 16q23. Using MCMC methods, all 4 families individually provided some support for linkage of PPD asbt2 to chromosome 16, with the highest IRs being 9.4 in family 1 and 7.6 in family 4. Families 3 and 4 had bimodal peaks on chromosome 16 (Figure 1 ), which may account for the wide peak seen in the analysis of the combined families ( Figure 2 ).
Analyses Without TG Adjustment
As expected, without the TG adjustment (PPD asb ), chromosome 9, 11, 14, and 16 linkage results substantially changed. The chromosome 9p family 1 2-point z max dropped from 2.89 to 0.83. The combined family chromosome 14 2-point z max dropped from 1.31 to 0.46, the chromosome 16 from 1.66 to 0.55, and chromosome 11 (85 cM) z max from 1.52 to 0.45. Considering all 4 families, the strongest signal for PPD asb was suggestive evidence for linkage to the APOA1/C3/A5 gene cluster. In family 3, the ordered markers D11S1986 (118 cM), APOC3 (123 cM), and D11S1998 (126 cM) suggested linkage to PPD asb with z max ϭ1.95, 0.37, and 1.81, respectively. The APOC3 marker had a high rate of homozygosity in key individuals 14 and thus lower informativeness for linkage analysis in this data set. In this region, the 2-marker (D11S2000-D11S1986) multipoint z max ϭ2.59 in family 3. All families had positive lod scores in this region, and the combined families yielded z max ϭ1.87 at D11S1998 and a 2-marker z max ϭ2.08. The APOC3 region gave no evidence of linkage when LDL size was adjusted for TG levels.
Other regions with z max Ͼ1.5 for PPD asb across all 4 families combined included 1.52 at marker D1S1609 and 1.85 at D14S599. Each family had a single z max Ͼ2: family 1 had z max ϭ2.29 at D19S433; family 2 had 2.17 at D21S1446; family 3 had z max ϭ2.09 at D9S1838; and family 4 had z max ϭ3.17 at D20S480. None of these regions overlapped with regions of interest for PPD asbt .
Discussion
We present evidence for the existence of 4 loci that influence TG-adjusted LDL PPD on chromosomes 9p, 11q, 14q, and 16q in a sample of 4 large FCHL pedigrees. LDL PPD has all the hallmarks of a complex trait, yet we were able to obtain strong and consistent evidence of linkage with statistically efficient model-based analyses by using a combination of 2 methods: a classic lod score and also a MCMC joint oligogenic segregation and linkage analysis approach. With both methods, we obtained strong evidence of linkage to chromosome 9p in a single family, and to chromosomes 11q and 16q in a joint analysis of all 4 families. In addition, we found consistent evidence for linkage at chromosome 14q24, which was stronger for the MCMC than the lod score method.
Our results, along with highly suggestive linkage to this region reported by Bosse et al, 19 are highly consistent with a locus in this 14q region detected in 2 very different populations. Despite the lack of a standard criterion for significance of the IR, comparison of IR signals that are known to be significant by lod methods should suggest the range of IR consistent with linkage within a data set. The IR of 71 for the chromosome 14 region was intermediate to the IRs of chromosomes 11 and 16, regions that were significant across all families by the lod score method. Similarly, the single family IR of 24 was equivalent to chromosome 9 IR of 21, which also corresponded to a significant lod score. IRs for individual family analyses are not comparable to the IRs from the larger data set of all families combined. A second line of evidence supporting a 14q QTL is that this was a highly suggestive region (lod scoreϭ2.8) in the only other reported scan of TG-adjusted LDL PPD, which used a FrenchCanadian population. 19 At sequential markers D14S592 (74 cM), D14S588 (84 cM; our peak), and D14S53 (97 cM), Bosse et al reported a z max ϭ1.73, 1.44, and 2.79. The dip at D14S588 may be attributable to less information or genotyping errors at the marker. We did not genotype D14S53, the marker at which the Bosse group reported their peak; instead, we genotyped D14S606 at 103 cM. The stronger results by MCMC than the lod score method may suggest that this locus is less consistent with the prespecified model used by the lod score analyses than chromosome 9, 11, and 16 loci. It is unclear to what extent the loci detected here are involved in the etiology of FCHL in these families, but there is growing evidence that FCHL is a multifactorial trait, and these may be contributing loci.
Our results support genetic heterogeneity in LDL size loci across and within families. MCMC methods originally estimated between 2 and 3 QTLs per family, and in these analyses, each family had 2 to 3 regions, with IRs Ͼ10, consistent with the original predictions. In the presence of locus heterogeneity, loci detected by individual studies are expected to vary with the population sampled and the method of ascertainment of the families. 54, 55 The detection of LDL size loci in families with FCHL is consistent with the excess of small, dense LDL seen in subjects with FCHL. 9, 23, 24 That we detect multiple loci here suggests that even within FCHL, multiple loci contribute to variation in LDL size variation. This genetic heterogeneity is a major obstacle for the mapping and cloning of novel LDL size loci and will require strategies to minimize heterogeneity within a sample, such as the use of large families with similar features, as well as analytic methods that are more robust to heterogeneity and can provide relatively accurate gene localization such as MCMC.
Essential to this mapping success was the demonstration that PPD adjusted for TG, in addition to age, sex, and BMI, had a larger genetic contribution from a codominant single locus than did PPD not adjusted for TG. Indeed, linkage results on LDL PPD adjusted for age, sex, and BMI but not TG failed to detect any significant evidence of linkage, reducing the linkage evidence at the regions identified with TG adjustment and giving suggestive evidence (lod scores 2.1 to 2.6) in the APOA1/C3/A5 region. The stronger linkage results for TG adjusted LDL PPD suggests that the loci detected are not TG loci that are detected because of the relationship of TG and LDL size. Alternatively, the APOA1/ C3/A5 cluster is known to affect TG 56 -58 and has been suggested as an FCHL susceptibility locus. 59 -61 Polymorphisms in this cluster have also been linked to HDL-C levels in these FCHL families. 14 Comparison of results of the MCMC and lod score results was illuminating. The computational requirements differed. The single marker lod score analyses were faster than the MCMC analyses. In contrast, the MCMC multipoint analyses, incorporating all markers on a chromosome, were much faster than the 2-or 3-marker lod score analyses. Indeed, 3-marker lod score analyses were the limit of what was computationally practical in these pedigrees. The 2 methods gave generally consistent results, but there were also some differences. Both methods detected linkage to chromosomes 11 and 16 across all families combined. Although evidence from the lod score methods for a chromosome 14 QTL was only suggestive, evidence from the MCMC analysis was stronger for chromosome 14 than for 16. This may reflect differences in the number of markers that can be accommodated, the trait model that is estimated, or some other difference. For both methods, the chromosome 9 signal was only detected when family 1 was analyzed separately. Given the strength of this signal using lod score methods, it was initially surprising that there was no signal in the combined family set when analyzed by MCMC methods. This, as well as other strong signals seen in the MCMC single family analyses but not in the combined analyses, suggests that when a family is large enough, single family analyses by MCMC may yield information not found in the combined analyses. This may be a particular issue when ascertainment procedures differ among pedigrees.
Several other observations on the MCMC methods were made. First, single-family analyses supported locus heterogeneity between families, suggesting the specific families that were responsible for the linkage peaks in the combined family MCMC analysis. When families are not large, this might be approached by analyzing all but 1 family at a time to see which families contribute to the signal. 62 Second, the large improvement in the IR for chromosome 9p linkage when preadjusted PPD asbt data were analyzed instead of PPD asbt2 being estimated within the MCMC analyses supports the concern that the available data in single families may be insufficient for accurate simultaneous estimation of trait models and covariate adjustments. Conversely, the IR for chromosome 16 remained Ϸ40 across the combined families when the preadjusted data were analyzed instead of the raw data, which may be expected given the larger data set used to estimate the covariate effects within the MCMC analysis.
Strong candidate genes that occur at regions we identify as potentially harboring LDL size loci are summarized in Table  2 . The CETP locus on chromosome 16q13 lies between markers D16S3253 and GATA67G11 and, although not located at the signal peak, may contribute to this linkage signal, particularly if undetected genotyping errors or mutations exist or if there are multiple QTLs across the families. As discussed above, CETP has established effects on LDL size. Lecithin-cholesterol acyltransferase is further telomeric at 16q22.1 and has shown linkage to FCHL in 1 study. 63 Without the TG adjustment of PPD, the chromosome 11 lod score peak was at the APOA1/C3/A5 gene cluster region, (120 cM) 35 cM from the peak for PPD with the TG adjustment (85 cM). The peak at the APOA1/C3/A5 gene cluster without but not with TG adjustment suggests that the linkage signal for PPD asbt at 85 cM is a separate locus from that at the APOA1/C3/A5 cluster. Bosse et al 19 also detected a z max ϭ2.4 for PPD adjusted for age at the chromosome 5q region, near 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), where we detected a multipoint z max ϭ1.42 across families and z max ϭ1.56 in family 2.
In summary, lod score and MCMC results yielded significant linkage evidence for a chromosome 9p locus for LDL size in a single family with FCHL as well as significant evidence in all families combined for chromosome 11q and 16q loci. Our results also support previous evidence of linkage to chromosome 14q. Use of MCMC and lod score analyses in this complex trait were complementary. Identification of LDL size loci will aid in diagnosis, treatment, and perhaps prevention of vascular disease, as well as help unravel the complex genetics of FCHL.
